Suppr超能文献

调强放疗联合深吸气屏气技术在纵隔霍奇金淋巴瘤患者中的剂量学优势。

Dosimetric benefits of intensity-modulated radiotherapy combined with the deep-inspiration breath-hold technique in patients with mediastinal Hodgkin's lymphoma.

机构信息

Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France.

出版信息

Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1522-7. doi: 10.1016/j.ijrobp.2011.05.015. Epub 2011 Jun 24.

Abstract

PURPOSE

To assess the additional benefits of using the deep-inspiration breath-hold (DIBH) technique with intensity-modulated radiotherapy (IMRT) in terms of the protection of organs at risk for patients with mediastinal Hodgkin's disease.

METHODS AND MATERIALS

Patients with early-stage Hodgkin's lymphoma with mediastinal involvement were entered into the study. Two simulation computed tomography scans were performed for each patient: one using the free-breathing (FB) technique and the other using the DIBH technique with a dedicated spirometer. The clinical target volume, planning target volume (PTV), and organs at risk were determined on both computed tomography scans according to the guidelines of the European Organization for Research and Treatment of Cancer. In both cases, 30 Gy in 15 fractions was prescribed. The dosimetric parameters retrieved for the statistical analysis were PTV coverage, mean heart dose, mean coronary artery dose, mean lung dose, and lung V20.

RESULTS

There were no significant differences in PTV coverage between the two techniques (FB vs. DIBH). The mean doses delivered to the coronary arteries, heart, and lungs were significantly reduced by 15% to 20% using DIBH compared with FB, and the lung V20 was reduced by almost one third. The dose reduction to organs at risk was greater for masses in the upper part of the mediastinum. IMRT with DIBH was partially implemented in 1 patient. This combination will be extended to other patients in the near future.

CONCLUSIONS

Radiation exposure of the coronary arteries, heart, and lungs in patients with mediastinal Hodgkin's lymphoma was greatly reduced using DIBH with IMRT. The greatest benefit was obtained for tumors in the upper part of the mediastinum. The possibility of a wider use in clinical practice is currently under investigation in our department.

摘要

目的

评估深度吸气屏气(DIBH)技术联合调强放疗(IMRT)在保护纵隔霍奇金淋巴瘤患者危险器官方面的额外获益。

方法和材料

本研究纳入了纵隔受累的早期霍奇金淋巴瘤患者。每位患者均进行两次模拟 CT 扫描:一次采用自由呼吸(FB)技术,另一次采用专用肺活量计行 DIBH 技术。根据欧洲癌症研究与治疗组织(EORTC)的指南,在两次扫描中均确定临床靶区(CTV)、计划靶区(PTV)和危险器官。两种情况下均处方 30 Gy/15 次。为进行统计学分析,检索了 PTV 覆盖度、心脏平均剂量、冠状动脉平均剂量、平均肺剂量和肺 V20 等剂量学参数。

结果

两种技术(FB 与 DIBH)的 PTV 覆盖度无显著差异。与 FB 相比,DIBH 可使冠状动脉、心脏和肺的平均剂量分别降低 15%~20%,肺 V20 降低近三分之一。纵隔上部肿块的危险器官剂量降低更为显著。1 例患者实施了部分 DIBH 联合 IMRT,近期将推广应用于其他患者。

结论

采用 DIBH 联合 IMRT 可显著降低纵隔霍奇金淋巴瘤患者的冠状动脉、心脏和肺的放射暴露。纵隔上部肿瘤获益最大。目前,我们科室正在研究更广泛应用的可能性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验